نتایج جستجو برای: adefovir

تعداد نتایج: 862  

Journal: :The new microbiologica 2008
Tiziano Allice Francesco Cerutti Fabrizia Pittaluga Silvia Varetto Silvia Gabella Alfredo Marzano Alessandro Franchello Valeria Ghisetti

Performances of the new automatic system COBAS AmpliPrep/COBAS TaqMan 48 (CAP/CTM) (Roche, Branchburg, NJ) for HBV DNA extraction and real-time PCR quantification were assessed and compared with the endpoint PCR COBAS AMPLICOR HBV Monitor (CAHBM, Roche). Analytical evaluation with proficiency panels from UK National External Quality Assessment Scheme (UK NEQAS) over a 1-year period of distribut...

2016
Xiaxia Zhang Minran Li Hongli Xi Renwen Zhang Jianhong Chen Yu Zhang Xiaoyuan Xu

AIMS The dynamics of resistance-associated mutations under combination therapy were explored. METHODS A total of 46 patients were classified into adefovir (n=14) and entecavir (n=32) groups. In the adefovir (ADV) group, six patients receiving combined therapy were DNA-positive after more than 3 years of therapy. Ultra-deep pyrosequencing was used to analyze the dynamics of multi-drugs resista...

Journal: :Antiviral research 2000
N D Christensen M D Pickel L R Budgeon J W Kreider

A series of nucleoside analogues were tested for in vivo anti-papillomavirus activity using the cottontail rabbit papillomavirus (CRPV) domestic rabbit model. Compounds were delivered either topically, injected into growing papillomas, or delivered subcutaneously at a site remote from the papillomas. Compounds tested included cidofovir [(S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine] (HPMP...

Journal: :Antimicrobial agents and chemotherapy 2003
Marc Pfister Line Labbé Scott M Hammer John Mellors Kara K Bennett Susan Rosenkranz Lewis B Sheiner

The present population pharmacokinetic (PK) and pharmacodynamic (PD) study modeled the effects of covariates including drug adherence and the coadministration of protease inhibitors (PIs) on the pharmacokinetics of efavirenz (EFV) and the relationship between EFV exposure and virological failure in patients who failed initial PI treatment in Adult AIDS Clinical Trial Group (AACTG) study 398. We...

Journal: :BMC Veterinary Research 2006
K van der Meulen B Garré S Croubels H Nauwynck

BACKGROUND Feline herpesvirus 1 (FHV-1) is a common cause of respiratory and ocular disease in cats. Especially in young kittens that have not yet reached the age of vaccination, but already lost maternal immunity, severe disease may occur. Therefore, there is a need for an effective antiviral treatment. In the present study, the efficacy of six antiviral drugs, i.e. acyclovir, ganciclovir, cid...

Journal: :Molecular medicine reports 2016
Shaolong Chen Jing Wu Erli Gu Yaojie Shen Feifei Wang Wenhong Zhang

Virological breakthrough is a clinical manifestation in patients infected with chronic hepatitis B (CHB), who undergo treatment with nucleoside/nucleotide analogs (NUCs). The current understanding of the underlying mechanism of virological breakthrough is limited. Ultra‑deep pyrosequencing (UDPS) is a novel and powerful tool used to investigate minor viral variants and viral evolution. The pres...

Journal: :Kidney international 2005
Michael L Moritz Juan C Ayus

To the Editor: We read with interest the excellent article of Daugas et al [1] on HAART-related nephropathies and we would like to clarify several points. There has been no case report of Fanconi syndrome (FS) related to reverse transcriptase inhibitors (RTIs) except one induced by didanosine [2]. Actually, the suspected case of nevirapine-induced FS was largely related to lactic acidosis rathe...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید